BioPlan Associates’ 12th Annual Report and Survey of BioManufacturing, the industry's definitive, quantitative analysis has been released, including 12 years of biopharma trends analysis and review of current opportunities. The report analyzes the growth of biomanufacturing in both developed and emerging economies, and along with this the need for much greater productivity. The report includes in-depth coverage of critical issues affecting the industry, ranging from budgets, downstream processing and single-use systems to mAbs, biosimilars and outsourcing.
The study contains 497 pages, 200+ graphs and 20 tables of quantitative data-rich analysis gleaned from 237 biomanufacturers and 164 supplier professionals in 28 countries to help improve your decision-making. Top trends identified include:
• Focus today is on cost-cutting, including steps to improve productivity and manufacturing
• U.S. and EU are stepping up their Biosimilars pipeline
• Hiring growing rapidly in key areas; 51% of companies unable to hire the right PD staff
• China is now the #1 "potential" outsourcing destination
Please visit
http://www.bioplanassociates.com/publications/bmcp.htm for more information about the report.